Carmichael Hill & Associates’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$910 Hold
2024
Q2
$521 Hold
2024
Q1
$701 Hold
2023
Q4
$872 Hold
2023
Q3
$614 Hold
2023
Q2
$952 Hold
2023
Q1
$1.02K Hold
2022
Q4
$1.17K Hold
2022
Q3
$1K Hold
2022
Q2
$0 Buy